Clinical Trial Update: Clinical Study of Stalevo in the Treatment of Early Parkinson's Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for Stalevo in early Parkinson's disease is listed with unknown status but ongoing investigation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Stalevo (levodopa;carbidopa;entacapone)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Parkinson Disease | Phase 4 | Status: UNKNOWN